CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-07-24. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v1.0.
Verdict No. 1794 · Search date 2026-07-24 · Methodology v1.0

EMDR,
does it really help with Improvement in core PTSD symptoms and diagnostic status?

30-Second Summary
C
Evidence Grade C · 54 · Safety caution
EMDR is an evidence-based PTSD therapy but has not proved superior to other trauma-focused psychotherapy
Revisiting traumatic memories can cause temporary symptom worsening and emotional distress, so a trained therapist and a crisis plan are required.
What the
research shows
EMDR reduces PTSD symptoms versus wait-list or inactive controls but is rated C. Power 2002 randomized 105 patients to EMDR, 39; exposure plus cognitive restructuring, 37; or wait-list, 29, but only 72 had end-of-treatment assessment, for 31.4% attrition. Both active treatments improved versus wait-list but did not differ from each other. Chen's Hedges g of -0.662 (95% CI -0.887 to -0.436, 22 trials) excluded studies with active psychotherapy controls and therefore represents comparison with wait-list or inactive controls.
What the
ads claim
Promotion can imply that eye movements erase memory or cure trauma in one or two sessions. Studied EMDR is a complete structured trauma-focused therapy delivered by a trained clinician.
*

Useful facts when choosing a product

  • EMDR is a structured psychotherapy incorporating trauma-memory recall, bilateral stimulation, and cognitive and emotional processing phases.
  • Patients and therapists cannot be blinded, so passive and active psychotherapy controls must be distinguished.
ID

Chamgap Semantic Classification Code

Candidate index · review held

X.eye-movement-desensitization-and-reprocessing.behavioral.core-ptsd-symptoms-and-diagnostic-status.improve.active

Behaviors, exposures and policies > Eye movement desensitization and reprocessing > Behavioral delivery > core PTSD symptoms and diagnostic status > Improvement claim > Active comparator

An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.

Download semantic index (JSON) · Codebook v1

Gap Measurement · Verdict 1794 · C 54
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Power and colleagues randomized 105 patients to EMDR, exposure plus cognitive restructuring, or wait-list, and only 72 had end-of-treatment assessment, for 31.4% attrition. Both active treatments improved significantly versus wait-list, but EMDR and exposure plus cognitive restructuring did not differ. The paper's clinically significant change rule required movement two standard deviations from the pretreatment group mean under a Jacobson-style criterion. Chen 2014 synthesized 26 randomized trials; after excluding studies with active psychotherapy controls, Hedges g across 22 trials comparing with wait-list or inactive controls was -0.662 (95% CI -0.887 to -0.436). In the same indication, sertraline is verdict 893, which is B with 67 points; prazosin is verdict 1206, which is C with 52 points; and stellate ganglion block is verdict 1774, which is C with 48 points. Those drug and injection interventions occupy different evidence tracks.

02

Why this is classified as C (54)

The pooled PTSD effect against wait-list or inactive controls is positive, but superiority over active psychotherapy and attainment of a disorder-specific important threshold were not established, giving E~. Small size and 31.4% attrition give B2, yielding C with 54 points.

Counterpoint. Therapist skill, dissociation, suicide risk, comorbidity, and patient preference can make exposure therapy, cognitive processing therapy, medication, or another evidence-based option more appropriate.

Rejudgment record. Cross-check applied — Scored absent superiority over active psychotherapy as E~ and small size plus 31.4% attrition as B2

Stored scoring profile
EndpointPSymptom or function itself is the target - including patient reports and performance tests
ReplicationR2Independently replicated across trials
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE~Statistically positive but below the threshold

Stored derived and displayed grades match; this is not a current recalculation or validity check (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduction of core PTSD symptomsCThe pooled effect across 22 randomized trials was moderate to large.
Improvement in PTSD diagnostic statusCMultiple trials found more loss of diagnosis after treatment than control.
Reduction of anxiety and subjective distressCThe meta-analysis also found significant reductions in anxiety and subjective distress.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Power K et al. 2002Randomized three-arm trial with wait-list and active psychotherapy controls105 randomized; 72 assessed at end of treatmentFunding source inadequately reported in the original article; university and NHS primary-care research rather than a manufacturer product trialPrincipal PTSD symptom measures including CAPS and clinically significant changeEMDR and exposure plus cognitive restructuring improved outcomes versus wait-list, with no difference between active treatments; clinically significant change used a Jacobson-style rule of moving two standard deviations from the pretreatment mean.Key trial containing both passive and active controls
Chen YR et al. 2014Systematic review and meta-analysis of randomized trials26 randomized trials; 22 assessed PTSD symptomsAcademic research from Taipei Medical University and Taiwanese institutions; no manufacturer funding reportedPTSD symptoms, depression, anxiety, and subjective distressAfter excluding studies with active psychotherapy controls, PTSD symptom Hedges g versus wait-list or inactive controls was -0.662 (95% CI -0.887 to -0.436).Independent multi-trial replication
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-07-24).

Power K, McGoldrick T, Brown K, et al. A controlled comparison of eye movement desensitization and reprocessing versus exposure plus cognitive restructuring versus waiting list in the treatment of post-traumatic stress disorder. Clin Psychol Psychother. 2002;9(5):299-318. DOI: 10.1002/cpp.341.
checked
Chen YR, Hung KW, Tsai JC, et al. Efficacy of eye-movement desensitization and reprocessing for patients with posttraumatic-stress disorder: a meta-analysis of randomized controlled trials. PLoS One. 2014;9(8):e103676. PMID: 25101684. DOI: 10.1371/journal.pone.0103676.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Evidence date: 2026-07-24 · Corrections: none

Cite this verdict

EMDR x relief of PTSD symptoms Evidence Grade C card
[Chamgap] EMDR x relief of PTSD symptoms — Evidence Grade C·54. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/mood/emdr-ptsd-symptom-reduction/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.